The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples G.B. Rogers, P. Marsh, A.F. Stressmann, C.E. Allen,

Slides:

Advertisements

Similar presentations

Genomic analysis of three African strains of Bacillus anthracis demonstrates that they are part of the clonal expansion of an exclusively pathogenic bacterium.

Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease

G. Cornaglia, A. Lönnroth, M. Struelens

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones J. Mensa, A. Trilla

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Antimicrobial susceptibility testing in biofilm-growing bacteria

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

An eye-catching acanthocephalan

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis T.W.V. Daniels, G.B. Rogers, F.A. Stressmann, C.J.

A. Oliver, A. Mena Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus P.O. Verhoeven, F. Grattard,

F. Bittar, J.-M. Rolain Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

Recent developments in staphylococcal scalded skin syndrome

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

The role of antimalarial treatment in the elimination of malaria

M. Bassetti, M.P. Molinari, M. Mussap, C. Viscoli, E. Righi

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Benchmarking inappropriate empirical antibiotic treatment

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

Antimicrobial drug development – the past, the present, and the future

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples G.B. Rogers, P. Marsh, A.F. Stressmann, C.E. Allen, T.V.W. Daniels, M.P. Carroll, K.D. Bruce Clinical Microbiology and Infection Volume 16, Issue 11, Pages 1656-1658 (November 2010) DOI: 10.1111/j.1469-0691.2010.03189.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Pseudomonas aeruginosa loads in sputum sample before and after intravenous antibiotics, with and without propidium monoazide (PMA) treatment. Error bars represent standard error. Clinical Microbiology and Infection 2010 16, 1656-1658DOI: (10.1111/j.1469-0691.2010.03189.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions